342 related articles for article (PubMed ID: 26576752)
1. Impact of Positive Margins on Survival in Patients Undergoing Esophagogastrectomy for Esophageal Cancer.
Javidfar J; Speicher PJ; Hartwig MG; D'Amico TA; Berry MF
Ann Thorac Surg; 2016 Mar; 101(3):1060-7. PubMed ID: 26576752
[TBL] [Abstract][Full Text] [Related]
2. Sex Disparities After Induction Chemoradiotherapy and Esophagogastrectomy for Esophageal Cancer.
Rowse PG; Jaroszewski DE; Thomas M; Harold K; Harmsen WS; Shen KR
Ann Thorac Surg; 2017 Oct; 104(4):1147-1152. PubMed ID: 28842111
[TBL] [Abstract][Full Text] [Related]
3. Survival in Patients With Esophageal Adenocarcinoma Undergoing Trimodality Therapy Is Independent of Regional Lymph Node Location.
Sepesi B; Schmidt HE; Lada M; Correa AM; Walsh GL; Mehran RJ; Rice DC; Roth JA; Vaporciyan AA; Ajani JA; Watson TJ; Swisher SG; Low DE; Hofstetter WL
Ann Thorac Surg; 2016 Mar; 101(3):1075-80; Discussion 1080-1. PubMed ID: 26680311
[TBL] [Abstract][Full Text] [Related]
4. Consequences of Refusing Surgery for Esophageal Cancer: A National Cancer Database Analysis.
Rahouma M; Harrison S; Kamel M; Nasar A; Lee B; Port J; Altorki N; Stiles B
Ann Thorac Surg; 2018 Nov; 106(5):1476-1483. PubMed ID: 30055137
[TBL] [Abstract][Full Text] [Related]
5. Risk Factors for Local Recurrence and Optimal Length of Esophagectomy in Esophageal Squamous Cell Carcinoma.
Kang CH; Hwang Y; Lee HJ; Park IK; Kim YT
Ann Thorac Surg; 2016 Oct; 102(4):1074-80. PubMed ID: 27302078
[TBL] [Abstract][Full Text] [Related]
6. Safety and benefit of curative surgical resection for esophageal squamous cell cancer associated with multiple primary cancers.
Otowa Y; Nakamura T; Takiguchi G; Yamamoto M; Kanaji S; Imanishi T; Oshikiri T; Suzuki S; Tanaka K; Kakeji Y
Eur J Surg Oncol; 2016 Mar; 42(3):407-11. PubMed ID: 26733367
[TBL] [Abstract][Full Text] [Related]
7. Concurrent chemoradiotherapy with or without surgery for patients with resectable esophageal cancer: An analysis of the National Cancer Data Base.
Naik KB; Liu Y; Goodman M; Gillespie TW; Pickens A; Force SD; Steuer CE; Owonikoko TK; Ramalingam SS; Higgins K; Beitler JJ; Shin DM; Willingham FF; El-Rayes B; Landry JC; Fernandez FG; Saba NF
Cancer; 2017 Sep; 123(18):3476-3485. PubMed ID: 28464264
[TBL] [Abstract][Full Text] [Related]
8. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
[TBL] [Abstract][Full Text] [Related]
9. Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes.
Shao MS; Wong AT; Schwartz D; Weiner JP; Schreiber D
Ann Thorac Surg; 2016 Jun; 101(6):2148-54. PubMed ID: 27016842
[TBL] [Abstract][Full Text] [Related]
10. The status of perineural invasion predicts the outcomes of postoperative radiotherapy in locally advanced esophageal squamous cell carcinoma.
Ning ZH; Zhao W; Li XD; Chen LJ; Xu B; Gu WD; Shao YJ; Xu Y; Huang J; Pei HL; Jiang JT
Int J Clin Exp Pathol; 2015; 8(6):6881-90. PubMed ID: 26261575
[TBL] [Abstract][Full Text] [Related]
11. Outcomes With Open and Minimally Invasive Ivor Lewis Esophagectomy After Neoadjuvant Therapy.
Tapias LF; Mathisen DJ; Wright CD; Wain JC; Gaissert HA; Muniappan A; Lanuti M; Donahue DM; Morse CR
Ann Thorac Surg; 2016 Mar; 101(3):1097-103. PubMed ID: 26652140
[TBL] [Abstract][Full Text] [Related]
12. Positive impact of radiation dose on disease free survival and locoregional control in postoperative radiotherapy for squamous cell carcinoma of esophagus.
Moon S; Kim H; Chie E; Kim J; Park C
Dis Esophagus; 2009; 22(4):298-304. PubMed ID: 19021683
[TBL] [Abstract][Full Text] [Related]
13. Association of positive transection margins with gastric cancer survival and local recurrence.
Bickenbach KA; Gonen M; Strong V; Brennan MF; Coit DG
Ann Surg Oncol; 2013 Aug; 20(8):2663-8. PubMed ID: 23536054
[TBL] [Abstract][Full Text] [Related]
14. Aggressive surgical resection does not improve survival in operable esophageal squamous cell carcinoma with N2-3 status.
Zheng YZ; Zhao W; Hu Y; Ding-Lin XX; Wen J; Yang H; Liu QW; Luo KJ; Huang QY; Chen JY; Fu JH
World J Gastroenterol; 2015 Jul; 21(28):8644-52. PubMed ID: 26229406
[TBL] [Abstract][Full Text] [Related]
15. Clinical T2-T3N0M0 esophageal cancer: the risk of node positive disease.
Stiles BM; Mirza F; Coppolino A; Port JL; Lee PC; Paul S; Altorki NK
Ann Thorac Surg; 2011 Aug; 92(2):491-6; discussion 496-8. PubMed ID: 21704291
[TBL] [Abstract][Full Text] [Related]
16. Association of perioperative fluid balance and adverse surgical outcomes in esophageal cancer and esophagogastric junction cancer.
Wei S; Tian J; Song X; Chen Y
Ann Thorac Surg; 2008 Jul; 86(1):266-72. PubMed ID: 18573435
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of the number of negative lymph nodes in esophageal cancer patients after transthoracic resection.
Hsu PK; Huang CS; Wang BY; Wu YC; Chou TY; Hsu WH
Ann Thorac Surg; 2013 Sep; 96(3):995-1001. PubMed ID: 23866797
[TBL] [Abstract][Full Text] [Related]
18. Early recurrence and death after esophagectomy in patients with esophageal squamous cell carcinoma.
Zhu ZJ; Hu Y; Zhao YF; Chen XZ; Chen LQ; Chen YT
Ann Thorac Surg; 2011 May; 91(5):1502-8. PubMed ID: 21354552
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of circumferential resection margin in esophageal squamous cell carcinoma after concurrent chemoradiation therapy and surgery.
Liu CY; Wang BY; Lee MY; Tsai YC; Liu CC; Shih CH
J Chin Med Assoc; 2013 Oct; 76(10):570-5. PubMed ID: 23938149
[TBL] [Abstract][Full Text] [Related]
20. Evolving progress in oncologic and operative outcomes for esophageal and junctional cancer: lessons from the experience of a high-volume center.
Reynolds JV; Donohoe CL; McGillycuddy E; Ravi N; O'Toole D; O'Byrne K; Hollywood D
J Thorac Cardiovasc Surg; 2012 May; 143(5):1130-1137.e1. PubMed ID: 22244551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]